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The fact that malignant neoplasms may have a remote effect on the nervous system has only recently been widely recognized but now that people have become interested in the subject it has been found that the clinical symptoms and pathological changes which may occur are very numerous. The Registrar General's Office give the total deaths from malignant tumours in England and Wales in 1964 as 104,698 (56,247 males and 48,451 females) . If 6% of these have a carcinomatous neuromyopathy, as our studies of the incidence have shown (Croft & Wilkinson 1965) over 6,000 people at any one time will have clinical evidence of a carcinomatous neuromyopathy. The incidence of carcinomatous neuromyopathy is highest in patients with carcinoma of the lung (14%) and as over 17,000 patients died from primary growths of the trachea, bronchus and lung in 1964, over 2,500 of these had a carcinomatous neuromyopathy. This gives some idea of the size of the problem involved. When we refer to the carcinomatous neuromyopathies we exclude any patients in whom the neurological symptoms and signs could be due to secondaries.
Case reports illustrating the co-existence of carcinoma with various neurological symptoms go back well into the last century but until recently the association was regarded by most writers as fortuitous.
Auche (1890) and Klippel (1899) are exceptions to this as Klippel commented that cancer produces its effects both as a tumour by direct actionusually pressureon the nervous system, and also by producing a cachexia probably due to intoxication from absorbed toxins or disturbance of nutrition. These two modes of action of the growth constituted a fundamental division, since although the effects of compression or invasion of the nerve, spinal cord and brain had been known for a long time, the metabolic effect of the cancer had not previously been recognized. He then described the neuromuscular disturbances, cerebral disorders including terminal delirium and psychoses with pathological lesions in the muscles, nerves and spinal cord which might occur in patients with cancer and in general states of debility. Auche described the existence of peripheral neuritis in patients with cancer and the histological changes he found in the nerves. Nerve compression was not the cause of the neuritis, and he thought that towards the end of an illness due to malignant disease the metabolic functions were disturbed by cachexia and were responsible for the changes in the nervous system. This work has largely been disregarded and it was not until the last twenty years that the causal relationship between the cancer and the neurological disorder was firmly established. The first clinical picture to be delineated was that of the sensory neuropathies; this was by Denny-Brown (1948) and was followed by a description of the mixed peripheral neuropathies by Lennox & Pritchard (1950) and of the subacute cerebellar degenerations by Brain et al. (1951) . At the London Hospital we have been interested in the remote effects of cancer on the nervous system for fifteen years, and for the last seven years we have been involved in an intensive prospective study of the problem. As our work has progressed it has become evident that any type of neuromyopathy may occur with any type of malignant disease, but that the highest incidence of neurological disorders is associated with carcinoma of the bronchus. However, some neurological syndromes commonly occur with neoplasms at other sites, the outstanding example of this being the occurrence of cerebellar degeneration with carcinoma of the ovary, a relatively uncommon neoplasm. Until a short time ago very little attempt had been made to make a classification of the types and sites of the neurological disorders which might occur with neoplasms. A Symposium was held in Rochester in October 1964, and following this Brain & Adams (1965) put forward a new classification of the carcinomatous neuromyopathies. They divided these disorders into the following groups:
The Encephalopathies (1) Multifocal leukoencephalopathy (2) Diffuse polioencephalopathy: One of the striking features of the histological appearances of the neoplastic neuromyopathies is the great variety of pathological processes responsible for the production of lesions in the central and peripheral nervous systems. These fall into four main groups: (1) Degenerative.
(2) Demyelinating. (3) Inflammatory. (4) Necrotizing. Although in a patient, any one of these pathological processes may be dominant, it is not uncommon to find evidence of more than one type of change.
Dr P B Croft and I have examined a series of 1,465 patients with carcinoma and, in addition, any patients who were referred to us because they were thought to have a neuromyopathy. In order to get some idea of the incidence of neuromyopathy in carcinoma at various sites we chose patients with carcinoma of the lung, breast, ovary, uterus, cervix, prostate, stomach, colon and rectum and we found the incidence in the series as a whole to be over 6 %. The patients in this series were unselected in that we were notified of all patients with carcinoma at these sites admitted to the London Hospital and to other hospitals which we visit. In addition to the series of 1,465 patients with cancer 200 control patients without cancer were examined. The controls were 100 men and 100 women whose age groups were similar to those of the patients with carcinoma of the lung and carcinoma of the breast (Croft & Wilkinson 1963) . The control patients were chosen from hospital in-patients who were not suspected of having cancer and who had no obvious neurological disease. In all patients detailed search was made for neurological abnormalities of the type seen in carcinomatous neuromyopathy. In only 2 of the 200 control patients were abnormalities found similar to those seen in the carcinomatous neuromyopathies, both having some diminution or loss of the reflexes. Table 1 shows the number of patients examined, the site of the primary cancer and the incidence of neuromyopathy in the series of 1,465 patients. The incidence is highest in patients with carcinoma of the lung, ovary and stomach and lowest in patients with carcinoma of the rectum, cervix and uterus. In the last three groups it does not Table 2 The incidence of some different types of carcinomatous neuromyopathy seen in routine examination of patients with carcinoma, and in selected patients referred because of evidence of neuromyopathy 
OPatients with mixed clinical pictures are included under each relevant heading differ significantly from the incidence in the control groups. Table 2 gives the incidence of the different types of neuromyopathy. The abnormality most commonly found is that called 'neuromuscular disorders'. These patients have diminution or loss of two or more reflexes with proximal weakness and wasting. As well as being the most frequent type of disorder this is also the one which is most likely to be missed as these patients are often severely ill with carcinoma and confined to bed, and any weakness of the legs may well be attributed to the general disorder. The striking point on examination is the difference in power between the proximal and distal muscles in the lower limbs. Although the patient may be so weak that he cannot lift his legs off the bed dorsiflexion of the feet may be normal and he may be able to walk but not to go upstairs. Reflex changes are easily discovered and the recognition of such abnormalities before operation is important because some patients with neuromyopathy are abnormally sensitive to muscle relaxants (Croft 1958) and this may well be an added hazard in any operative procedure.
In addition to the patients examined in our routine survey (Table 2 ' series') we also saw a group referred to us because of symptoms of carcinomatous neuromyopathy (Table 2 'selected') and we have given the incidence of carcinomatous neuromyopathy of these two groups separately. As was expected there is a considerable difference between the two. The less florid neuromuscular syndromes are relatively infrequent in the selected group while the grosser syndromes, i.e. cerebellar degeneration and sensory neuropathy, have a much higher incidence.
Exact classification of patients with the various types of neuromyopathy is often difficult because more than one part of the nervous system may be affected. Patients with mixed clinical pictures are included under each relevant heading in Table 2 . The tendency to involvement of more than one part of the nervous system is characteristic of the carcinomatous neuromyopathies. An interesting point is the time relationship of the development of the neuromyopathy to that of the cancer. The neurological symptoms may develop either before, at the same time as or after those of the neoplasm. If the symptoms of the neuromyopathy develop before those ofthe cancer it is reasonable to suppose that the cancer is present but is so small as to be undetectable, and this illustrates the point that the extent and severity of the neuromyopathy is independent of the size of the neoplasm.
THE ENCEPHALOPATHIES
MultifocalLeukoencephalopathy This is a demyelinating disease of the central nervous system which was described by Astrom et al. in 1958. The condition occurs most commonly as a complication of lymphomas and leukiemias but occasional cases have been reported associated with carcinoma and a number of non-neoplastic conditions. The diagnosis of multifocal leukoencephalopathy has usually been made only after death. It develops on a background of chronic disease often of many years' duration. The onset is insidious and progressive, leading to death in a few months. The patient develops signs and symptoms of diffuse but asymmetrical disease of the brain, including mental disturbances, hemiparesis, loss of vision, dysphasia or dysarthria and occasionally signs of brain-stem or cerebellar disturbance.
Diffuse Polioencephalopathy
(a) With mental symptoms: Dementia is a fairly common symptom in patients with carcinomatous neuromyopathy. This may be associated with the inflammatory encephalopathies, particularly limbic encephalitis (Henson et al. 1965) , or with degenerative processes such as cerebellar degeneration (Brain & Wilkinson 1965) . It may also occur in the absence of any focal lesion. Mental disorder associated with primary oat-cell carcinoma of the lung was described by Charatan & Brierley (1956) . In two of their patients psychotic features preceded the local symptoms and all three of their patients showed fluctuating toxic confusional psychosis with lucid intervals and no neurological signs. Other workers including Henson et al. (1954) have also noticed early mental changes not attributable to metastases. (b) Subacute cerebellar degeneration: This is a relatively uncommon form of carcinomatous neuromyopathy but the clinical picture is striking (Brain & Wilkinson 1965) . Over the course of a few weeks, or occasionally days, the patient develops severe bilateral disturbances of cerebellar function producing inability to stand, gross ataxia of the arms and severe dysarthria so that the speech becomes almost unintelligible. There may also be mental disturbances. In a severe case the patient may be so disabled that he is unable to sit up in bed. The primary growth is most frequently a bronchial carcinoma but it is of interest that carcinoma of the ovary is the next most common responsible neoplasm. The CSF often shows changes including pleocytosis and slight rise of protein with a paretic Lange. (c) Brain-stem lesions: In this group of patients with carcinoma there is evidence of damage to the brainstem and spinal cord and post-mortem examination reveals histopathological evidence of extensive inflammatory lesions.
The wide variation of symptoms and signs found in this group is the result of the differing distribution and severity of lesions in the nervous system. The duration of the neurological illness varies considerably and in our series was from five to twenty months. In some cases the symptoms cease to progress and the patient may remain in an unchanged neurological state for several months, while on the other hand patients with severe involvement of bulbar or spinal motor neurones may show a progressive course until death.
Clinical Syndromes by P B Croft BM MRCP THE MYELOPATHIES
The spinal cord is involved in several types of carcinomatous neuromyopathy and may be the primary site of damage to the nervous system. Cord changes are found in association with subacute cerebellar degeneration, and in patients with encephalomyelitis due to carcinoma. Secondary changes in the cord may occur, the most striking example of which is the Wallerian degeneration in the posterior columns of patients with sensory neuropathy, who may also have involvement of the anterior horn cells.
Motor Neurone Disease
We have recently described a small group of patients in whom a neurological disorder closely resembling motor neurone disease occurs in association with various types of growth (Brain et al. 1965) . The clinical features are largely indistinguishable from those of classical motor neurone disease, having a combination of upper and lower motor neurone symptoms and signs, though the disease runs a rather more benign course than classical motor neurone disease. One patient in this group showed an unexpected improvement in his neurological disorder following removal of the bronchial carcinoma, but eventually died from the effects of cerebral metastases.
It might be argued that the occurrence of motor neurone disease and a major malignant disorder in the same patient is no more than a coincidence. A review of 86 patients with classical motor neurone disease showed only one patient in whom an unconfirmed carcinoma of the lung may have been present in the terminal stages. Norris & Engel (1965) found 13 (10%) patients with major malignant disorders in 130 patients with motor neurone disease, but this figure is very much higher than that found by other workers.
The recognition of this type of neuromyopathy makes it imperative to try to exclude possible malignant disease in patients with the symptoms and signs suggesting motor neurone disease. A chest X-ray should be done as a routine, and any atypical clinical features should reinforce the need for further investigations. If a tumour is found, the presence of an apparently incurable neurological disorder should not be regarded as a contraindication to surgical or other possible treatment of the carcinoma. Subacute Necrotic Myelopathy This is a very rare form of myelopathy associated with malignant disease in which there is massive necrosis in the cord (Mancall & Rosales 1964). As with other types of carcinomatous neuromyopathy, the patient may be known to have a carcinoma before the neurological disorder develops, or the neurological symptoms may precede the discovery of the growth which may not be found until post-mortem examination is made. The patient develops subacutely an ascending sensorimotor myelopathy which usually does not extend above the dorsal cord though occasionally the cervical region is involved. The paraplegia is generally flaccid with loss of reflexes and the patient frequently dies within two months. The findings in the cerebrospinal fluid are variable, there being in some cases an increase of cells or protein, possibly associated with a paretic Lange, while in others the fluid is normal.
